Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.
CTL Laboratories provides contract laboratory services to pharmaceutical and biotechnology companies, government agencies, and academic institutions. CTL specializes in Cell Mediated Immune Monitoring services for research, preclinical studies, and clinical trials.
With a focus on high-throughput ELISPOT assays, multiplex Cytokine Bead Arrays (CBA), Flow Cytometry (phenotyping, multimer readouts etc.), and BrdU proliferation assays, CTL is uniquely capable of developing, qualifying and validating assays tailored to our clients' specific needs in our GLP-compliant and CLIA-certified laboratory.